吸入麻酔市場レポート：製品、用途、エンドユーザー、地域別、2024～2032年

世界の吸入麻酔市場規模は2023年に16億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに21億6,000万米ドルに達し、2024～2032年の間に3.1%の成長率（CAGR）を示すと予測しています。慢性疾患の増加、製薬会社、医療機器メーカー、医療機関の連携、政府と民間医療プロバイダーによる最先端機器への投資の増加は、市場を推進している主要要因の一部です。

吸入麻酔市場分析

市場の成長と規模同市場は着実な成長を遂げており、その背景には世界の外科手術の増加や医療インフラの進歩があります。また、様々な外科手術における麻酔需要の高まりが吸入麻酔市場の成長を後押ししています。

主要市場促進要因：慢性疾患の有病率の増加、高齢者人口の拡大、手術における吸入麻酔の利点に関する意識の高まりなどが市場を牽引する主要要因です。また、麻酔デリバリーシステムの技術進歩や新しい麻酔薬の採用が市場成長を刺激しています。

主要市場動向：吸入麻酔業界動向には、迅速な麻酔開始、容易な投与、迅速な回復などの利点により、外来手術センターでの吸入麻酔の採用が増加していることが含まれます。さらに、環境への影響を最小限に抑えるため、環境に優しい麻酔薬やデリバリーシステムの開発へとシフトしています。

地理的動向：北米が市場をリードしているのは、医療インフラが整備されていること、手術率が高いこと、研究開発（R&D）活動が活発であることによる。しかし、アジア太平洋は、医療費の増加、医療施設の改善、患者数の多さなどを背景に、急成長市場として浮上しています。

競合情勢：同市場は、主要参入企業間の激しい競争が特徴です。各社は、市場での地位を強化し、製品ポートフォリオを拡大するため、M&A、製品上市、提携などの戦略的取り組みに注力しています。

課題と機会：同市場は、麻酔薬や麻酔デバイスの承認・商業化を規制する厳しい枠組みなどの課題に直面する一方で、低侵襲（MI）手術の需要の増加や、新規麻酔薬やデリバリー方法に関する継続的な研究活動により、新興市場において機会にも遭遇しています。

吸入麻酔市場傾向

麻酔薬とデリバリーシステムの継続的進歩

製薬会社や医療機器メーカーは、より効果的で安全な麻酔ガスや麻酔蒸気を開発するため、研究開発に多額の投資を行っています。これらの技術革新は、副作用のリスクを低減し、麻酔体験全体を改善することで、患者の転帰を向上させることを目的としています。薬剤動態プロファイルが改善された新しい薬剤が開発されており、麻酔の導入と麻酔からの覚醒をより迅速に行えるため、患者が手術室で過ごす時間が短縮されます。さらに、精密な気化器やモニタリング技術を含む高度な送達システムの開発により、麻酔薬の正確な投与と漸増が保証され、投与量の過不足の可能性が最小限に抑えられています。このような進歩は、患者ケアの向上に貢献するだけでなく、医療プロバイダーがこのような最新のソリューションを採用するきっかけにもなっており、吸入麻酔市場の成長を促進しています。

外科手術と患者数の増加

人口の増加は、高齢化社会を伴うことが多く、外科手術の需要の高まりに直結します。高齢者人口は、心血管疾患、人工関節置換術、がん治療など、加齢に伴う病気のために、より多くの医療介入を必要とする傾向があります。その結果、整形外科、心臓病学、腫瘍学、一般外科などの外科専門セグメントの需要が増加しています。吸入麻酔は、その迅速な麻酔開始と制御可能な鎮静の深さにより、これらの処置に好ましい選択肢であることが証明されています。吸入麻酔は、患者の無意識の確保と生理的安定性の維持のバランスを記載しています。さらに、医療的知識と技術の進歩は、実現可能な外科的介入の範囲を広げました。低侵襲手術、ロボット支援手術、その他の革新的な技術が登場し、より安全で迅速な介入が可能になりました。

外来手術センターの拡大

ASCは、費用対効果、患者滞在期間の短縮、院内感染リスクの低減など、数多くの利点を記載しています。吸入麻酔は、その迅速な麻酔開始と迅速な回復プロファイルのため、ASCの要件によく合致しています。ASCで手術を受ける患者は、日常生活により早く戻れる吸入麻酔を好むことが多いです。さらに、術後の吐き気や嘔吐を最小限に抑える吸入麻酔の能力は、外来では特に価値があります。外来手術の需要増に対応するためにASCの数が増えるにつれて、吸入麻酔の需要は大幅に増加すると予想されます。この動向はまた、ASC特有のニーズに合わせた、よりポータブルでユーザーフレンドリーな麻酔デリバリーシステムの開発をメーカーに促しています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の吸入麻酔市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品別

• デスフルラン
• セボフルラン
• イソフルラン
• その他

第7章 市場内訳：用途別

• 吸引
• 維持

第8章 市場内訳：エンドユーザー別

• 病院
• 外来手術センター
• その他

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbvie Inc.
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Halocarbon Products Corporation
  • Hikma Pharmaceuticals PLC
  • Lunan Pharmaceutical Group Co. Ltd
  • Merck KGaA
  • Piramal Enterprises Ltd.
  • Troikaa Pharmaceuticals Ltd

List of Figures

• Figure 1: Global: Inhalation Anesthesia Market: Major Drivers and Challenges
• Figure 2: Global: Inhalation Anesthesia Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Inhalation Anesthesia Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Inhalation Anesthesia Market: Breakup by Product (in %), 2023
• Figure 5: Global: Inhalation Anesthesia Market: Breakup by Application (in %), 2023
• Figure 6: Global: Inhalation Anesthesia Market: Breakup by End User (in %), 2023
• Figure 7: Global: Inhalation Anesthesia Market: Breakup by Region (in %), 2023
• Figure 8: Global: Inhalation Anesthesia (Desflurane) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Inhalation Anesthesia (Desflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Inhalation Anesthesia (Sevoflurane) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Inhalation Anesthesia (Sevoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Inhalation Anesthesia (Isoflurane) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Inhalation Anesthesia (Isoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Inhalation Anesthesia (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Inhalation Anesthesia (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Inhalation Anesthesia (Induction) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Inhalation Anesthesia (Induction) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Inhalation Anesthesia (Maintenance) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Inhalation Anesthesia (Maintenance) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Inhalation Anesthesia (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Inhalation Anesthesia (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: Global: Inhalation Anesthesia (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: Global: Inhalation Anesthesia (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: North America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: North America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: United States: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: United States: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Canada: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Canada: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: Asia-Pacific: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: Asia-Pacific: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: China: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: China: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: Japan: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: Japan: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: India: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: India: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: South Korea: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: South Korea: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Australia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Australia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Indonesia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Indonesia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: Europe: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: Europe: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: Germany: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: Germany: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: France: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: France: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: United Kingdom: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: United Kingdom: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Italy: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Italy: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: Spain: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: Spain: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: Russia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: Russia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Latin America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Latin America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Brazil: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Brazil: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Mexico: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Mexico: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 72: Middle East and Africa: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
• Figure 73: Middle East and Africa: Inhalation Anesthesia Market: Breakup by Country (in %), 2023
• Figure 74: Middle East and Africa: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 75: Global: Inhalation Anesthesia Industry: SWOT Analysis
• Figure 76: Global: Inhalation Anesthesia Industry: Value Chain Analysis
• Figure 77: Global: Inhalation Anesthesia Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Inhalation Anesthesia Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Inhalation Anesthesia Market Forecast: Breakup by Product (in Million US$), 2024-2032
• Table 3: Global: Inhalation Anesthesia Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 4: Global: Inhalation Anesthesia Market Forecast: Breakup by End User (in Million US$), 2024-2032
• Table 5: Global: Inhalation Anesthesia Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Inhalation Anesthesia Market: Competitive Structure
• Table 7: Global: Inhalation Anesthesia Market: Key Players

The global inhalation anesthesia market size reached US$ 1.60 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.16 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032. The increasing prevalence of chronic medical disorders, collaborations between pharmaceutical companies, medical device manufacturers, and healthcare institutions, and the rising investments by governments and private healthcare providers in state-of-the-art equipment are some of the major factors propelling the market.

Inhalation Anesthesia Market Analysis:

Market Growth and Size: The market is witnessing steady growth, which can be attributed to increasing surgical procedures worldwide and advancements in healthcare infrastructure. In addition, the rising demand for anesthesia in various surgical procedures is propelling the inhalation anesthesia market growth.

Major Market Drivers: The growing prevalence of chronic diseases, expanding geriatric population, and rising awareness about the benefits of inhalation anesthesia in surgeries are some of the key factors driving the market. Additionally, technological advancements in anesthesia delivery systems and the introduction of new anesthetic agents are stimulating the market growth.

Key Market Trends: Inhalation anesthesia Industry trends include the increasing adoption of inhalation anesthesia in ambulatory surgical centers due to its advantages, such as rapid onset, easy administration, and faster recovery. Moreover, there is a shift towards the development of eco-friendly anesthetic agents and delivery systems to minimize environmental impact.

Geographical Trends: North America leads the market owing to its well-established healthcare infrastructure, high surgical procedure rates, and robust research and development (R&D) activities. However, Asia Pacific is emerging as a fast-growing market, driven by rising healthcare expenditures, improving healthcare facilities, and a large patient pool.

Competitive Landscape: The market is characterized by intense competition among key players. They are focusing on strategic initiatives, such as mergers and acquisitions (M&A), product launches, and collaborations, to strengthen their market position and expand their product portfolios.

Challenges and Opportunities: While the market faces challenges, such as stringent regulatory framework governing the approval and commercialization of anesthesia drugs and devices, it also encounters opportunities in in emerging markets due to the increasing demand for minimally invasive (MI) surgeries and ongoing research activities on novel anesthetic agents and delivery methods.

Inhalation Anesthesia Market Trends:

Continual Advancements in Anesthetic Agents and Delivery Systems

Pharmaceutical companies and medical device manufacturers are heavily investing in research and development to create more effective and safer anesthetic gases and vapors. These innovations aim to enhance patient outcomes by reducing the risk of adverse effects and improving the overall anesthesia experience. Newer agents are being developed with improved pharmacokinetic profiles, enabling faster induction and emergence from anesthesia, thus shortening the time patients spend in the operating room. Furthermore, the development of sophisticated delivery systems, including precise vaporizers and monitoring technologies, ensures accurate administration and titration of anesthetic agents, minimizing the chances of over or under dosing. These advancements not only contribute to better patient care but also attract healthcare providers to adopt these modern solutions, thus catalyzing the growth of the inhalation anesthesia market.

Rising Surgical Procedures and Patient Volume

Population growth, often accompanied by an aging demographic, directly correlates with a heightened demand for surgical procedures. The elderly population tends to require more medical interventions due to age-related ailments, such as cardiovascular diseases, joint replacements, and cancer treatments. Consequently, surgical specialties such as orthopedics, cardiology, oncology, and general surgery have seen a rise in demand. Inhalation anesthesia proves to be a preferred option for these procedures due to its rapid onset and controllable depth of sedation. It offers a balance between ensuring patient's unconsciousness and maintaining their physiological stability. Furthermore, the expansion of medical knowledge and technology has broadened the spectrum of feasible surgical interventions. Minimally invasive procedures, robotics-assisted surgeries, and other innovative techniques have emerged, allowing for safer and quicker interventions.

Expansion of Ambulatory Surgical Centers

ASCs offer numerous advantages, such as cost-effectiveness, shorter patient stays, and reduced risk of hospital-acquired infections. Inhalation anesthesia aligns well with the requirements of ASCs due to its rapid onset and quick recovery profile. Patients undergoing procedures at ASCs often prefer inhalation anesthesia as it allows them to return to their daily activities more swiftly. Moreover, inhalation anesthesia's ability to minimize post-operative nausea and vomiting is particularly valuable in an outpatient setting. As the number of ASCs grows to accommodate the increasing demand for outpatient surgeries, the demand for inhalation anesthesia is expected to witness a significant rise. This trend also encourages manufacturers to develop more portable and user-friendly anesthesia delivery systems tailored to the unique needs of ASCs.

Inhalation Anesthesia Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global inhalation anesthesia market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Desflurane

Sevoflurane

Isoflurane

Others

Sevoflurane dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes desflurane, sevoflurane, isoflurane, and others. According to the report, sevoflurane represented the largest segment.

Sevoflurane's popularity is largely due to its favorable pharmacokinetic profile. With its rapid induction and emergence characteristics, sevoflurane enables anesthesiologists to guide patients swiftly and smoothly into and out of anesthesia. This not only enhances operational efficiency in medical settings but also ensures that patients experience minimal delay in the start and conclusion of surgical procedures. Moreover, sevoflurane's low blood-gas solubility allows for rapid equilibration between the lungs and the bloodstream, translating into quicker adjustments in the depth of anesthesia and the potential for faster recoveries. Sevoflurane's reduced likelihood of causing organ toxicity or compromising vital functions offers a degree of reassurance to both medical professionals and patients. This safety aspect has been pivotal in cementing sevoflurane's role as a cornerstone of inhalation anesthesia practice, particularly in paediatric and geriatric populations where safety is of paramount concern.

Breakup by Application:

Induction

Maintenance

Maintenance dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes induction and maintenance. According to the report, maintenance represented the largest segment.

The prominence of the maintenance phase is attributed to its role in ensuring patient comfort, surgical precision, and optimal outcomes. Once the patient is induced into anesthesia and the initial surgical incisions are made, maintaining the appropriate anesthetic depth becomes paramount. Anesthesia providers carefully titrate inhalation anesthetic agents to balance the patient's need for complete insensitivity to pain while avoiding over-sedation, which could lead to complications or lengthened recovery times. This dynamic balance requires continuous monitoring and adjustment throughout the procedure, highlighting the importance of skilled anesthesiologists. Moreover, the maintenance phase is directly linked to surgical efficacy and precision. Surgeons rely on patients being adequately anesthetized and immobilized to perform delicate procedures with accuracy. Any fluctuation in the anesthesia depth during the maintenance phase could lead to patient movement or awareness, potentially compromising the surgery's success.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.

Hospitals offer a diverse range of medical services, encompassing routine surgeries, emergency interventions, and specialized procedures across various medical specialties. The sheer volume and variety of surgical interventions conducted in hospitals create a substantial demand for anesthesia services, and inhalation anesthesia, with its ability to provide rapid induction and adjustable sedation levels, aligns seamlessly with the dynamic environment of hospital operating rooms. Additionally, hospitals provide a comprehensive infrastructure for anesthesia administration and patient care. They possess well-equipped operating suites, sophisticated monitoring systems, and experienced anesthesia teams capable of managing a wide spectrum of cases. This robust setup allows hospitals to efficiently manage the complexities associated with different surgeries, including those requiring inhalation anesthesia. Furthermore, the presence of specialized units within hospitals, such as pediatric and cardiac surgery departments, highlights the versatility of inhalation anesthesia across diverse patient populations and procedural requirements.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest inhalation anesthesia market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is characterized by its emphasis on medical advancements and innovation. The presence of renowned research institutions, academic medical centers, and cutting-edge pharmaceutical companies fosters an environment conducive to the development of new anesthetic agents, delivery methods, and monitoring technologies. This commitment to innovation not only enhances patient care but also attracts healthcare professionals to adopt state-of-the-art anesthesia practices, including inhalation anesthesia techniques. The region's regulatory landscape and adherence to stringent safety standards further contribute to its dominance. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) play a pivotal role in ensuring the safety and efficacy of anesthesia agents and equipment. This rigorous oversight augments the confidence of healthcare providers and patients in the use of inhalation anesthesia, solidifying North America's position as a leader in the field. Also, North America's focus on medical education and training ensures that anesthesia providers are well-equipped to administer inhalation anesthesia safely and efficiently.

Competitive Landscape:

Pharmaceutical and medical device companies are heavily investing in research and development to create advanced anesthetic agents, delivery systems, and monitoring technologies. Moroever, companies are frequently introducing new inhalation anesthesia products and equipment to cater to the evolving needs of healthcare providers and patients. These products often incorporate the latest technological advancements, such as more precise vaporizers, integrated monitoring systems, and user-friendly interfaces. Additionally, leading players are focusing on developing innovative technologies that enhance the administration and monitoring of inhalation anesthesia. This includes the integration of electronic medical records (EMR) systems, real-time data analysis, and remote monitoring capabilities to ensure optimal patient care and safety. Additionally, numerous companies are providing training and educational programs to healthcare professionals, including anesthesiologists, nurse anaesthetists, and operating room staff. These programs help ensure that healthcare providers are well-versed in the latest techniques, technologies, and safety measures related to inhalation anesthesia.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbvie Inc.

Baxter International Inc.

Fresenius SE & Co. KGaA

Halocarbon Products Corporation

Hikma Pharmaceuticals PLC

Lunan Pharmaceutical Group Co. Ltd

Merck KGaA

Piramal Enterprises Ltd.

Troikaa Pharmaceuticals Ltd.

Recent Developments:

In May 2023, Piramal Enterprises Ltd collaborated with plus therapeutics to meet increase in investigational drug demand for ongoing and planned clinical trials.

In April 2023, Baxter International Inc. launched Zosyn Premix. It is indicated for the treatment of multiple infections caused by susceptible bacteria.

In December 2021, Hikma Pharmaceuticals PLC launched Bupivacaine HCl Injection. Bupivacaine HCl Injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.

Key Questions Answered in This Report

• 1. What was the size of the global inhalation anesthesia market in 2023?
• 2. What is the expected growth rate of the global inhalation anesthesia market during 2024-2032?
• 3. What are the key factors driving the global inhalation anesthesia market?
• 4. What has been the impact of COVID-19 on the global inhalation anesthesia market?
• 5. What is the breakup of the global inhalation anesthesia market based on the product?
• 6. What is the breakup of the global inhalation anesthesia market based on the application?
• 7. What is the breakup of the global inhalation anesthesia market based on the end user?
• 8. What are the key regions in the global inhalation anesthesia market?
• 9. Who are the key players/companies in the global inhalation anesthesia market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Inhalation Anesthesia Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Desflurane
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Sevoflurane
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Isoflurane
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Application

• 7.1 Induction
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Maintenance
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbvie Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Baxter International Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Fresenius SE & Co. KGaA
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Halocarbon Products Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Hikma Pharmaceuticals PLC
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Lunan Pharmaceutical Group Co. Ltd
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Merck KGaA
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Piramal Enterprises Ltd.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Troikaa Pharmaceuticals Ltd
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio